RxDoctor Payments Data

Cody Pittman, APRN

Psychiatric/Mental Health · Louisville, KYNPI 1205422839

Payments from drug & device makers

$843in general payments, 2019–2025

Across 84 payments — averaging $10.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$463
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$83
  • Ironshore Pharmaceuticals Inc.$64
  • Otsuka America Pharmaceutical, Inc.$44
  • Corium, LLC$44
  • AbbVie$41
  • plus $104 from 5 others

What the payments were for

  • Food & beverage$78994%
  • Education$546%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$843 in reported general payments places this provider in the 50th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$12,738
Medicare patients
49
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl28$58,661
RexultiBrexpiprazole13$18,766
TrintellixVortioxetine Hydrobromide11$11,203
VyvanseLisdexamfetamine Dimesylate25$9,720
Lisdexamfetamine Dimesylate18$3,219
Lamotrigine ErLamotrigine11$704
Desvenlafaxine Succinate ErDesvenlafaxine Succinate26$546
Aripiprazole25$385
Bupropion Hcl SrBupropion Hcl12$353
Fluoxetine Hcl14$241
Buspirone Hcl12$198
Gabapentin28$162
Quetiapine Fumarate22$131
Sertraline Hcl22$100
Alprazolam25$76

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$41$58,66128 claims
Otsuka America Pharmaceutical, Inc.Rexulti$44$18,76613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →